Showing 2,681 - 2,700 results of 20,793 for search '"therapy"', query time: 0.11s Refine Results
  1. 2681

    Oligonucleotide-Based Therapy for FTD/ALS Caused by the C9orf72 Repeat Expansion: A Perspective by Stephanie A. Fernandes, Andrew G. L. Douglas, Miguel A. Varela, Matthew J. A. Wood, Yoshitsugu Aoki

    Published 2013-01-01
    “…Antisense oligonucleotides (ASOs) are modified nucleic acids that are able to silence targeted mRNAs or perform splice modulation, and the fact that they have proved efficient in repeat expansion diseases including myotonic dystrophy type 1 makes them ideal candidates for c9FTD/ALS therapy. Here, we discuss potential mechanisms and challenges for developing oligonucleotide-based therapy for c9FTD/ALS.…”
    Get full text
    Article
  2. 2682
  3. 2683

    Effect of Different Stages of Chronic Kidney Disease and Renal Replacement Therapies on Oxidant-Antioxidant Balance in Uremic Patients by Hadja Fatima Tbahriti, Abbou Kaddous, Malika Bouchenak, Khedidja Mekki

    Published 2013-01-01
    “…In this study, we determined the effect of different stages of CKD and substitutive therapies on oxidative stress. One hundred sixty-seven patients (age: 44±06 years; male/female: 76/91) with CKD were divided into 6 groups according to the National Kidney Foundation classification. …”
    Get full text
    Article
  4. 2684
  5. 2685
  6. 2686

    Response to 1-Year Fixed-Regimen Bevacizumab Therapy in Treatment-Naïve DME Patients: Assessment by OCT Angiography by Magdalena Hunt, Sławomir Teper, Adam Wylęgała, Edward Wylęgała

    Published 2022-01-01
    “…The fixed-regimen intravitreal bevacizumab therapy was effective in treating DME. Apart from noninvasive visualization of microvascular damage, OCT-A showed limited usefulness in predicting treatment response. …”
    Get full text
    Article
  7. 2687
  8. 2688
  9. 2689

    Patients outcomes in lung adenocarcinoma transforming to small-cell lung cancer after tyrosine kinase inhibitor therapy by Shuai Wang, Yongsen Wang, Xuan Wu, Li Yang, Xiaoju Zhang

    Published 2025-02-01
    “…In the univariate analysis, ever smoking (either former or current) was a promising predictor of a shorter ttSCLC (HR, 1.73; 95% CI, 1.14 to 2.62; P = 0.010). TKIs therapy administered as a second line and beyond treatment was related to a significant delay in SCLC onset compared to first-line therapy (HR, 0.62; 95% CI, 0.40 to 0.96; P = 0.031). …”
    Get full text
    Article
  10. 2690

    Diffuse panbronchiolitis as a rare complication of thymectomy and radiation therapy in a patient with thymoma: a case report by Ye Lu, Qi Qi, Dan Qu, Yu Chen

    Published 2025-01-01
    “…Both thymectomy and radiation therapy can contribute to the development of DPB. …”
    Get full text
    Article
  11. 2691
  12. 2692
  13. 2693

    Feasibility of Proton Range Estimation with Prompt Gamma Imaging in Proton Therapy of Lung Cancer: Monte Carlo Study by Elham Rohollahpour, Hadi Taleshi Ahangari

    Published 2024-12-01
    “…With 109 protons, it is feasible to utilize PGI as a real-time monitoring technique during proton therapy for lung cancer.…”
    Get full text
    Article
  14. 2694
  15. 2695
  16. 2696
  17. 2697
  18. 2698
  19. 2699
  20. 2700

    Partial Excision and Ablative Carbon Dioxide Fractional Laser Therapy for Multiple Apocrine Hidrocystomas on the Periorbital Regions and Cheeks by Hiroshi Kitagawa, Isao Sugimoto, Toshinori Bito, Keiichi Yamanaka, Hiroto Terashi

    Published 2023-01-01
    “…Approximately 1.5 years later, she underwent ablative 10,600 nm carbon dioxide fractional laser therapy for the mildly enlarged apocrine hidrocystomas on her lower eyelids and cheeks. …”
    Get full text
    Article